Peter Izmirly, M.D. Associate Professor of Medicine, NYU School of Medicine  Director of Inpatient Rheumatology, Bellevue Hospital Center co-Director, NYU-Hospital for Joint Diseases Lupus Clinic Research Office Address: NYU School of Medicine  New York, NY 10016

Lupus Affects Women and Minorities More Than Other Groups

MedicalResearch.com Interview with:

Peter Izmirly, M.D. Associate Professor of Medicine, NYU School of Medicine  Director of Inpatient Rheumatology, Bellevue Hospital Center co-Director, NYU-Hospital for Joint Diseases Lupus Clinic Research Office Address: NYU School of Medicine  New York, NY 10016

Dr. Izmirly

Peter Izmirly, M.D.
Associate Professor of Medicine, NYU School of Medicine
Director of Inpatient Rheumatology, Bellevue Hospital Center
co-Director, NYU-Hospital for Joint Diseases Lupus Clinic
Research Office Address:
NYU School of Medicine
New York, NY 10016 

MedicalResearch.com: What is the background for this study? What are the main findings?

Response: Knowing how many people have systemic lupus erythematosus (SLE) is limited, particularly for racial/ethnic subgroups in the United States.
Our work provides accurate estimates of who has  (SLE) among the major racial/ethnic groups in the United States and that our estimates for SLE approach the FDA’s definition or a rare disease.

MedicalResearch.com: What should readers take away from your report?

Response: SLE affects women and racial minorities more than other groups. Women are nine times more likely than men to be affected with SLE and American Indian and Alaska Native women and Black women had the highest race-specific lupus estimates. 

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: Further research is needed to understand the causes for the strong disparities by sex, race and ethnicity.

MedicalResearch.com: Is there anything else you would like to add?

Response: I would like to acknowledge that this study is a result of almost two decades of work from a network of five Centers of Disease Control and Prevention-funded population-based registries and would like to thank all the investigators and their teams involved with the registries.

Disclosures: I did a scientific advisory board for GSK in 2019. 

Citation:

Arthritis and Rheumatology
Izmirly, P.M., Parton, H., Wang, L., McCune, W.J., Lim, S.S., Drenkard, C., Ferucci, E.D., Dall’Era, M., Gordon, C., Helmick, C.G. and Somers, E.C. (2021), Prevalence of Systemic Lupus Erythematosus in the United States: Estimates from a Meta‐Analysis of the Centers for Disease Control and Prevention National Lupus Registries. Arthritis & Rheumatology. Accepted Author Manuscript. https://doi.org/10.1002/art.41632

JOIN OUR EMAIL LIST

We respect your privacy and will never share your details.

Jan 21, 2021 @ 4:51 pm 

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.